Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ferrous Acetyl-Aspartate Casein Formulation Evaluation Over Ferrous Sulfate in Iron Deficiency Anemia (ACCESS): A Double-Dummy Randomized Clinical Trial

NCT03524651 is registered in ClinicalTrials.gov with Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. as lead sponsor.

NCT NCT03524651
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03524651 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ferrous Acetyl-Aspartate Casein Formulation Evaluation Over Ferrous Sulfate in Iron Deficiency Anemia (ACCESS): A Double-Dummy Randomized Clinical Trial
Lead sponsor
Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.
Phase
Phase 4
Overall status
Completed
Start date
May 2, 2018
Completion date
January 8, 2021
Enrollment
60 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

iron deficiency anemia